All companies
Visit website
Oracle Health
OperatingORACLE HEALTH, INC.
Biotech · Founded 2019
Tiny implantable cardiac device using telemedicine and AI
Post-money valuation ⓘ
$44.2M
As of Apr 2025 · from FUTURE CARDIA Common Stock 3 · pre-money + amount raised, not a traded price
Total raised
$17,014,630
Across 7 rounds since 2020
Latest share price
$2.00
Reg CF Offering (2024) offering price
Financials
FY2017–FY2025 · from SEC filings · hover any figure for its source$0
−$36K
2018
$0
−$90K
2019
$0
−$727K
2020
$0
−$1.7M
2021
$0
−$3.5M
2022
$0
−$3.5M
2023
$0
$4.7M
2024
$0
$5.7M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Chart shows the most recent 8 fiscal years; 1 earlier year is in the table below.
Metric
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$0
$0
$0
$0
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$674,026
$0
$0
$0
$0
$0
Net income
$0
-$36,212
-$90,119
-$727,320
-$1,738,609
-$3,488,821
-$3,502,822
$4,666,858
$5,682,583
Taxes paid
$0
$0
$0
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$0
$15,933
$0
$328,368
$2,391,353
$3,737,737
$2,157,697
$919,993
$113,697
Accounts receivable
$0
$0
$0
$0
$0
$1,335
$0
$0
$0
Total assets
$0
$23,878
$29,966
$328,368
$2,391,353
$3,764,974
$2,197,031
$1,031,114
$211,170
Short-term debt
$0
$0
$120,000
$4,440
$73,680
$119,079
$416,484
$900,365
$1,150,713
Long-term debt
$0
$0
$0
$762,106
$1,492,106
$688,106
$422,106
$767,106
$738,106
Total liabilities
$0
$0
$509,994
$766,546
$1,565,786
$807,185
$915,034
$1,667,471
$1,888,819
Other
Headcount
—
1
1
1
1
13
5
13
15
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$23.3M
post-money
$50.0M
post-money
$43.6M
post-money
$44.2M
post-money
$56.5M
post-money
Oracle Health Stock 2
Future Cardia
Future Cardia Common Stock Round 2023
FUTURE CARDIA Common Stock 3
Reg A Offering (2024)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $1.5M / $3.1MInvestors 1,731
Raised $5.5M / $15.5MInvestors 2,626Post-money $56.5M
Reg CF annual-report compliance
Not required3+ reports filed & assets ≤ $10M
Filed 6 of 7 annual reports (FY2019–FY2025)
3,692 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 72 filings on EDGARSource: ManualCIK 0001777274Share price $2.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.